Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis-Reference-Cited by-同舟云学术

Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis

Published:2021-04-26 Issue:4 Volume:13 Page:82-94
ISSN:1949-8462
Container-title:World Journal of Cardiology
language:
Short-container-title:WJC

Author:

Li Wei-Jia,Archontakis-Barakakis Paraschos,Palaiodimos Leonidas,Kalaitzoglou Dimitrios,Tzelves Lazaros,Manolopoulos Apostolos,Wang Yu-Chiang,Giannopoulos Stefanos,Faillace Robert,Kokkinidis Damianos G

Publisher

Baishideng Publishing Group Inc.

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Global Burden of Stroke

2. Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials

3. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

4. Stroke prevention in atrial fibrillation

5. Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillation;World Journal of Cardiology;2022-11-26

2. Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation;Journal of Clinical Gastroenterology;2022-11-15

3. Major Hemorrhage Risk Associated with Direct Oral Anticoagulants in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis;Reviews in Cardiovascular Medicine;2022-10-10

4. Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta‐analysis of 92 studies;British Journal of Clinical Pharmacology;2022-08-15